tiprankstipranks
Trending News
More News >
PYC Therapeutics Limited (AU:PYC)
ASX:PYC
Australian Market

PYC Therapeutics Limited (PYC) Financial Statements

Compare
39 Followers

PYC Therapeutics Limited Financial Overview

PYC Therapeutics Limited's market cap is currently AU$956.55M. The company's EPS TTM is AU$-0.046; its P/E ratio is -16.22; PYC Therapeutics Limited is scheduled to report earnings on August 28, 2025, and the estimated EPS forecast is AU$-0.07. See an overview of income statement, balance sheet, and cash flow financials.
Dec 25Dec 24Dec 23Dec 22Dec 21
Income Statement
Total RevenueAU$ 23.49MAU$ 22.06MAU$ 15.81MAU$ 16.04MAU$ 3.07M
Gross ProfitAU$ 23.49MAU$ 22.06MAU$ 14.92MAU$ 15.20MAU$ 2.45M
Operating IncomeAU$ -53.63MAU$ -38.86MAU$ -39.16MAU$ -30.21MAU$ -21.83M
EBITDAAU$ -52.88MAU$ -54.55MAU$ -38.25MAU$ -29.39MAU$ -21.04M
Net IncomeAU$ -50.30MAU$ -37.73MAU$ -22.79MAU$ -13.86MAU$ -17.77M
Balance Sheet
Cash & Short-Term InvestmentsAU$ 153.05MAU$ 66.87MAU$ 15.57MAU$ 29.11MAU$ 51.50M
Total AssetsAU$ 183.28MAU$ 91.24MAU$ 37.17MAU$ 45.35MAU$ 57.94M
Total DebtAU$ 1.02MAU$ 1.11MAU$ 315.49KAU$ 943.77KAU$ 730.35K
Net DebtAU$ -152.03MAU$ -65.76MAU$ -15.26MAU$ -28.17MAU$ -17.70M
Total LiabilitiesAU$ 13.27MAU$ 10.18MAU$ 8.72MAU$ 5.15MAU$ 4.02M
Stockholders' EquityAU$ 169.57MAU$ 80.50MAU$ 27.75MAU$ 39.35MAU$ 53.04M
Cash Flow
Free Cash FlowAU$ -52.54MAU$ -38.90MAU$ -24.91MAU$ -22.17MAU$ -12.38M
Operating Cash FlowAU$ -51.56MAU$ -38.59MAU$ -24.42MAU$ -21.78MAU$ -11.79M
Investing Cash FlowAU$ -975.40KAU$ -307.04KAU$ -477.12KAU$ 32.68MAU$ -15.52M
Financing Cash FlowAU$ 138.66MAU$ 90.19MAU$ 11.44MAU$ -182.36KAU$ 38.56M
Currency in AUD

PYC Therapeutics Limited Earnings and Revenue History

PYC Therapeutics Limited Debt to Assets

PYC Therapeutics Limited Cash Flow

PYC Therapeutics Limited Forecast EPS vs Actual EPS